Why the study?
What are the risk factors associated with deep vein thrombosis and pulmonary thromboembolism in cancer patients?
What are the risk factors associated with deep vein thrombosis and pulmonary thromboembolism in cancer patients?
In cancer patients, non-O blood group, along with immobilization and recent surgery, is significantly associated with an increased risk of deep vein thrombosis and pulmonary thromboembolism.
Answers are grounded in this paper and cite their sources.
May inform thrombosis risk stratification in cancer; leaves open prospective validation before guiding practice.
Aim: To evaluate the factors associated with Deep vein thrombosis (DVT) and pulmonary thromboembolism (PTE) in cancer patients. Materials and Methods: A total of 237 cancer patients who underwent lower extremity venous Doppler Ultrasonography (USG) and/or pulmonary computed tomography angiography (PCTA) were included. Patients’ demographic characteristics; chemotherapy data; immobilization status; use of central venous catheter; histories of 4-day-long bed rest, surgery within the last 6 months, long anesthesia for at least 2 hours, smoking, patients’ laboratory tests, ABO blood group, PCTA and lower extremity Doppler USG results were retrospectively reviewed through the hospital information management system. Results: The median age was 62 (age range 25 to 89). Thrombosis was detected in 83 patients according to the results of venous Doppler USG and/or PCTA of those patients who underwent imaging. Immobilization status (p=0.019), history of surgery within the last 6 months (p=0.02), anesthesia more than 2 hours (p=0.012) and 4-day-long bed rest (p=0.03) were found to be significantly associated with related risk of thrombosis. Additionally, thrombosis was found more frequently in the non-O group (especially group B) than in O group (p:0.024). Conclusions: Besides well-known risk factors, blood group may be related with risk of thrombosis in the patients with the cancer diagnosis Keywords: ABO blood group, Cancer, Pulmonary thromboembolism, Deep vein thrombosis
No takes yet. Share an insight, caveat, or question.
Gökçe et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: